We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$265M
AUM Growth
+$8.72M
Cap. Flow
-$2.74M
Cap. Flow %
-1.04%
Top 10 Hldgs %
52.32%
Holding
59
New
5
Increased
9
Reduced
28
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 18.94%
3 Consumer Discretionary 12.06%
4 Financials 9.92%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLOP
26
DELISTED
GASLOG PARTNERS LP
GLOP
$3.13M 1.18%
143,750
-1,130
-0.8% -$22.6K
DLNG icon
27
Dynagas LNG Partners
DLNG
$123M
$3.07M 1.16%
198,415
-1,865
-0.9% -$27.3K
NLY icon
28
Annaly Capital Management
NLY
$16.9B
$2.57M 0.97%
61,150
-2,221
-4% -$96.2K
RUSHB icon
29
Rush Enterprises Class B
RUSHB
$5.89B
$2.36M 0.89%
218,761
+2,925
+1% +$30.5K
PKW icon
30
Invesco BuyBack Achievers ETF
PKW
$1.69B
$1.82M 0.69%
38,300
-101,110
-73% -$4.76M
PFE icon
31
Pfizer
PFE
$143B
$1.22M 0.46%
37,980
-1,070
-3% -$35.8K
BIIB icon
32
CALL
Biogen
BIIB
$30.4B
$939K 0.35%
3,000
BWP
33
DELISTED
Boardwalk Pipeline Partners
BWP
$896K 0.34%
52,200
-6,000
-10% -$101K
DSL
34
DoubleLine Income Solutions Fund
DSL
$1.22B
$646K 0.24%
33,720
CSCO icon
35
CALL
Cisco
CSCO
$441B
$602K 0.23%
19,000
BXE
36
DELISTED
Bellatrix Exploration Ltd.
BXE
$597K 0.23%
139,653
-18,000
-11% -$79.2K
GILD icon
37
CALL
Gilead Sciences
GILD
$167B
$593K 0.22%
7,500
+4,300
+134% +$349K
QHC
38
DELISTED
Quorum Health Corporation
QHC
$583K 0.22%
93,027
-869
-0.9% -$7.12K
DSX.PRB icon
39
Diana Shipping Inc 8.875% Series B Preferred Shares
DSX.PRB
$71.2M
$495K 0.19%
28,900
BAC icon
40
CALL
Bank of America
BAC
$430B
$470K 0.18%
+30,000
New +$447K
DCH
41
Dauch Corp
DCH
$1.29B
$389K 0.15%
22,600
REXX
42
DELISTED
Rex Energy Corporation
REXX
$382K 0.14%
65,444
-1,455
-2% -$8.6K
GLNG icon
43
Golar LNG
GLNG
$5.05B
$365K 0.14%
17,210
MGNX icon
44
MacroGenics
MGNX
$285M
$364K 0.14%
12,162
-3,673
-23% -$109K
KMI icon
45
Kinder Morgan
KMI
$71.9B
$337K 0.13%
14,570
CELG
46
CALL
DELISTED
Celgene Corp
CELG
$314K 0.12%
+3,000
New +$325K
AB icon
47
AllianceBernstein
AB
$3.54B
$263K 0.1%
11,550
PHM icon
48
CALL
Pultegroup
PHM
$24B
$261K 0.1%
13,000
LYB icon
49
LyondellBasell Industries
LYB
$19.1B
$242K 0.09%
3,000
MS icon
50
Morgan Stanley
MS
$339B
$209K 0.08%
+6,505
New +$194K

Similar funds

Muhlenkamp & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Muhlenkamp & Co held 59 positions worth $265M, up 3.4% from $256M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Muhlenkamp & Co's Q3 2016 filing shows 5 new, 9 increased, 28 reduced and 3 closed positions. Its largest new stake was Morgan Stanley: 6,505 shares worth $209K. The largest sale was Neustar Inc, an estimated $7.23M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Muhlenkamp & Co's largest Q3 2016 buy was Morgan Stanley: 6,505 shares worth $209K.
  • Muhlenkamp & Co added most to Celgene Corp in Q3 2016, an estimated $5.81M increase.
  • Muhlenkamp & Co's biggest Q3 2016 reduction was Invesco BuyBack Achievers ETF, cutting an estimated $4.76M.
  • Muhlenkamp & Co fully exited Neustar Inc in Q3 2016, selling an estimated $7.23M.
  • Muhlenkamp & Co's ten largest holdings make up 52% of its $265M portfolio in Q3 2016.
  • Muhlenkamp & Co opened 5 new positions and closed 3 in Q3 2016.
  • Muhlenkamp & Co's portfolio value rose 3.4% quarter-over-quarter to $265M.

Based on Muhlenkamp & Co's 13F filing for Q3 2016, filed 14 Nov 2016.